Answers are grounded in this paper and cite their sources.
Objectives Three-dimensional (3D) biomanufacturing has emerged as a cornerstone of tissue engineering by recreating physiologically relevant microenvironments. This review aims to integrate scaffold-free self-organization, scaffold-based biomimetic construction, and dynamic bioreactor culture into a unified framework and to chart the transition from structural biomimicry to functional integration. Methods An integrative literature review was performed across tissue engineering, biomaterials, bioengineering, and regenerative medicine. Representative studies were synthesized to compare scaffold-free, scaffold-based, and hybrid strategies; to clarify the distinction between multicellular spheroids and organoids; and to evaluate material-cell crosstalk, dynamic culture systems, and translational barriers. The reviewed technologies include spheroid and organoid models, natural, synthetic, and composite biomaterials, bioreactors, 4D printing, electroactive scaffolds, and organ-on-a-chip platforms. Results Scaffold-free systems preserve native cell-cell interactions but are limited by diffusion and scalability, whereas scaffold-based systems provide tunable mechanical and topographical cues through natural, synthetic, and composite biomaterials. Material properties regulate stem cell fate via YAP/TAZ mechanotransduction, and functional biomimicry is advanced by 4D printing, electroactive scaffolds, and stimuli-responsive materials. Integration with 3D bioprinting, microfluidics, and organ-on-a-chip platforms improves vascularization and intertissue communication. Bioreactors further enable scalable, physiologically relevant culture. Hybrid approaches that pair spheroids with scaffolds or bioreactors mitigate individual limitations and support macroscale tissue assembly. Key translational barriers remain vascularization, immune compatibility, GMP-compliant manufacturing, and standardization. Conclusions Hybrid systems that combine cellular self-organization with structural and dynamic cues offer the most promising route to functional tissue regeneration. A 5 to 10 year roadmap emphasizing vascularization, quality standardization, AI-driven process optimization, digital twins, and regulatory harmonization is proposed to accelerate clinical translation and personalized medicine.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: